Savvy Updates, 11/1/21: No Drug Price Restraints for 2022, Sonoma Bio & T-Regs, Interoception: How the Brain Senses, New BioTech IPOs, Amazing Med-Tech Entrepreneur

Savvy Updates, 11/1/21: No Drug Price Restraints for 2022, Sonoma Bio & T-Regs, Interoception: How the Brain Senses, New BioTech IPOs, Amazing Med-Tech Entrepreneur

Drug price restraints dropped as Biden prioritizes other measures was reported by Jonathan Bardner for BioPharmaDive.com, 29 October 2021.  Industry opposition appears to have toppled another administration’s effort to lower prices. No matter what your political leanings, as someone living with Type 1 diabetes, this has to make you angry and confused. 

Broad national drug pricing controls aren’t likely to be signed into law this year after President Joe Biden, facing congressional opposition, left them out a legislative negotiating framework for a package that includes health insurance, education and more support for household income.

Leave a Reply

Your email address will not be published. Required fields are marked *